Transforming vaccine development

The urgency to develop vaccines against Covid-19 is putting pressure on the long and expensive development timelines that are normally required for development of lifesaving vaccines. There is a unique opportunity to take advantage of new technologies, the smart and flexible design of clinical trial...

Descripción completa

Detalles Bibliográficos
Autores principales: Black, Steve, Bloom, David E., Kaslow, David C., Pecetta, Simone, Rappuoli, Rino
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd. 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7591868/
https://www.ncbi.nlm.nih.gov/pubmed/33127296
http://dx.doi.org/10.1016/j.smim.2020.101413
_version_ 1783601075766427648
author Black, Steve
Bloom, David E.
Kaslow, David C.
Pecetta, Simone
Rappuoli, Rino
author_facet Black, Steve
Bloom, David E.
Kaslow, David C.
Pecetta, Simone
Rappuoli, Rino
author_sort Black, Steve
collection PubMed
description The urgency to develop vaccines against Covid-19 is putting pressure on the long and expensive development timelines that are normally required for development of lifesaving vaccines. There is a unique opportunity to take advantage of new technologies, the smart and flexible design of clinical trials, and evolving regulatory science to speed up vaccine development against Covid-19 and transform vaccine development altogether.
format Online
Article
Text
id pubmed-7591868
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher The Author(s). Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-75918682020-10-28 Transforming vaccine development Black, Steve Bloom, David E. Kaslow, David C. Pecetta, Simone Rappuoli, Rino Semin Immunol Review The urgency to develop vaccines against Covid-19 is putting pressure on the long and expensive development timelines that are normally required for development of lifesaving vaccines. There is a unique opportunity to take advantage of new technologies, the smart and flexible design of clinical trials, and evolving regulatory science to speed up vaccine development against Covid-19 and transform vaccine development altogether. The Author(s). Published by Elsevier Ltd. 2020-08 2020-10-28 /pmc/articles/PMC7591868/ /pubmed/33127296 http://dx.doi.org/10.1016/j.smim.2020.101413 Text en © 2020 The Author(s) Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Review
Black, Steve
Bloom, David E.
Kaslow, David C.
Pecetta, Simone
Rappuoli, Rino
Transforming vaccine development
title Transforming vaccine development
title_full Transforming vaccine development
title_fullStr Transforming vaccine development
title_full_unstemmed Transforming vaccine development
title_short Transforming vaccine development
title_sort transforming vaccine development
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7591868/
https://www.ncbi.nlm.nih.gov/pubmed/33127296
http://dx.doi.org/10.1016/j.smim.2020.101413
work_keys_str_mv AT blacksteve transformingvaccinedevelopment
AT bloomdavide transformingvaccinedevelopment
AT kaslowdavidc transformingvaccinedevelopment
AT pecettasimone transformingvaccinedevelopment
AT rappuolirino transformingvaccinedevelopment

Ejemplares similares